glp-1 obesity drug news october 9 2025 How to Invest in Drugs: Stocks and Funds to Watch How Supply and Demand for

Obviously, the labeling of these meds is still pretty cautious on this, which is understandable, but Id argue that even with this reassuring evidence that we talked about that GLP-1 arent associated with suicide, we should honestly warn any patient about mood changes, depression, or suicidal ideation with any drug and refer them to help ASAP, such as contacting the crisis line at nine hundred eighty eight we mentioned earlier to keep them safe and of course, stop the med if there ever concerns for any of these symptoms

These articles were initially screened based on their titles and abstracts

Where the research stands and where its heading As the FDA has not approved GLP-1 drugs for addiction treatment, they are still not covered by insurance companies

For example, a meta-analysis of 21 trials found that obese patients experienced a BMI reduction of 1.3 units when using metformin at higher doses

Its tedious, the cost adds up, and the gastro issues during dose increases can be rough

Clinical studies have not generally documented serious side effects that require discontinuation of liraglutide, but gastrointestinal side effects, such as nausea, vomiting, and digestive disorders, often occur